News
King of Prussia, Pennsylvania– (Newsfile Corp. – July 25, 2025) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its ...
A review highlights the need for better research on pediatric segmental vitiligo treatments, as current options show mixed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback